Palisade Bio, Inc. (PALI)

Palisade Bio Statistics

Total Valuation

Palisade Bio has a market cap or net worth of $323.97 million. The enterprise value is $189.66 million.

Market Cap	323.97M
Enterprise Value	189.66M

Important Dates

The last earnings date was Tuesday, May 12, 2026, after market close.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Palisade Bio has 167.42 million shares outstanding. The number of shares has increased by 4,310.71% in one year.

Current Share Class	167.42M
Shares Outstanding	167.42M
Shares Change (YoY)	+4,310.71%
Shares Change (QoQ)	+1.99%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	69.55%
Float	127.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.45
P/TBV Ratio	2.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 23.71

Current Ratio	23.71
Quick Ratio	23.60
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2,649.40

Financial Efficiency

Return on equity (ROE) is -36.40% and return on invested capital (ROIC) is -24.95%.

Return on Equity (ROE)	-36.40%
Return on Assets (ROA)	-23.40%
Return on Invested Capital (ROIC)	-24.95%
Return on Capital Employed (ROCE)	-20.75%
Weighted Average Cost of Capital (WACC)	12.65%
Revenue Per Employee	n/a
Profits Per Employee	-$1.73M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +153.95% in the last 52 weeks. The beta is 1.53, so Palisade Bio's price volatility has been higher than the market average.

Beta (5Y)	1.53
52-Week Price Change	+153.95%
50-Day Moving Average	2.01
200-Day Moving Average	1.72
Relative Strength Index (RSI)	47.66
Average Volume (20 Days)	2,657,114

Short Selling Information

The latest short interest is 26.92 million, so 16.08% of the outstanding shares have been sold short.

Short Interest	26.92M
Short Previous Month	26.15M
Short % of Shares Out	16.08%
Short % of Float	21.13%
Short Ratio (days to cover)	6.87

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-26.49M
Pretax Income	-24.15M
Net Income	-24.15M
EBITDA	-26.49M
EBIT	-26.49M
Earnings Per Share (EPS)	-$0.23

Balance Sheet

The company has $132.63 million in cash and n/a in debt, with a net cash position of $132.63 million or $0.79 per share.

Cash & Cash Equivalents	132.63M
Total Debt	n/a
Net Cash	132.63M
Net Cash Per Share	$0.79
Equity (Book Value)	127.36M
Book Value Per Share	0.76
Working Capital	127.62M

Cash Flow

Operating Cash Flow	-12.40M
Capital Expenditures	n/a
Depreciation & Amortization	2,750
Net Borrowing	-311,000
Free Cash Flow	-12.40M
FCF Per Share	-$0.07

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Palisade Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4,310.71%
Shareholder Yield	-4,310.71%
Earnings Yield	-7.49%
FCF Yield	-3.85%

Analyst Forecast

The average price target for Palisade Bio is $9.71, which is 401.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.71
Price Target Difference	401.81%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 8, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	Apr 8, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	2